23:20 , Jul 26, 2019 |  BC Extra  |  Company News

Management tracks: Obsidian builds out team; plus Agilvax, Selvita, NeuBase and more

Obsidian Therapeutics (Cambridge, Mass.) hired Catherine Stehman-Breen as chief development officer, Ryan Daws as CFO, and Karen Brown as SVP, intellectual property and legal affairs. Stehman-Breen was CMO of Atlas Venture-backed Dyne Therapeutics Inc. (Cambridge,...
07:00 , Apr 30, 2012 |  BC Week In Review  |  Financial News

LeukoDx completes venture financing

LeukoDx L.P. , Towson, Md.   Business: Diagnostic   Date completed: 4/18/12   Type: Venture financing   Raised: $1.6 million   Investors: Existing investors; and other undisclosed investors   Note: The company raised $1.6 million...
08:00 , Jan 25, 2010 |  BC Week In Review  |  Company News

LeukoDx, Trillium Diagnostics deal

The companies signed a memorandum of understanding under which LeukoDx will receive exclusive, worldwide rights to Trillium's patent and technology covering the quantification of Fc gamma receptor I ( CD64 ; FCGR1 ) for point...
08:00 , Jan 18, 2010 |  BC Week In Review  |  Company News

LeukoDx management update

LeukoDx L.P. , Towson, Md.   Business: Diagnostic   Hired: Bruce Davis, founder and president of Trillium Diagnostics LLC , as CSO  ...